The coronavirus outbreak has taken a significant toll on daily life in China and in turn, the Chinese economy. Several major Chinese companies have experienced disruptions to their operations and this has affected their stocks. Let’s take a look at how the outbreak has impacted some of the leading players in China.
Alibaba
Alibaba (NYSE: BABA) expects the coronavirus outbreak to pose challenges to its business in the near-term. The company stated in its earnings call that its ecommerce business has been impacted by delays in employees returning to work and the inability of merchants and logistics companies to resume operations. The company’s travel booking service, Fliggy, witnessed a significant increase in cancellations for air tickets, tour packages and hotel reservations.
Alibaba believes its overall revenue growth rate for the March quarter will be negatively impacted by the outbreak. Its China Retail Marketplace and Local Consumer Services businesses are also expected to see a negative revenue growth for the quarter. Alibaba’s stock has dropped 8% in the past one month.
Also read: A look at how Dick’s Sporting Goods (DKS) will fare going forward
Baidu
Baidu (NASDAQ: BIDU) has forecast its revenues for the first quarter of 2020 to decline 5-13% year-over-year to a range of $3.0-3.3 billion, assuming its core revenue will decline 10-18% year-over-year. This guidance reflects the company’s preliminary view which faces uncertainty due to the fluid nature of the coronavirus situation. Baidu’s stock has dropped 17% in the past one month.
JD.com
JD.com (NASDAQ: JD) has not witnessed a significant negative impact from the outbreak compared to its peers. The company stated in its conference call that its proprietary supply chain and logistics network helped in resuming operations quickly and in providing uninterrupted service to customers. JD.com said that although large ticket durable goods and discretionary products were impacted by the outbreak, consumer staples such as groceries and household products witnessed a spike in demand. The company expects its net revenues to grow in the double digits for the first quarter of 2020. JD.com’s stock has gained 13% since the beginning of the year.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
